Oncogene- and drug resistance-associated alternative exon usage in acute myeloid leukemia (AML).
about
Aberrant splicing and drug resistance in AMLAberrant RNA splicing and mutations in spliceosome complex in acute myeloid leukemia.High expression of S100A8 gene is associated with drug resistance to etoposide and poor prognosis in acute myeloid leukemia through influencing the apoptosis pathway.Targeting acute myeloid leukemia stem cell signaling by natural products.A role for intracellular and extracellular DEK in regulating hematopoiesis.
P2860
Oncogene- and drug resistance-associated alternative exon usage in acute myeloid leukemia (AML).
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Oncogene- and drug resistance- ...... acute myeloid leukemia (AML).
@ast
Oncogene- and drug resistance- ...... acute myeloid leukemia (AML).
@en
type
label
Oncogene- and drug resistance- ...... acute myeloid leukemia (AML).
@ast
Oncogene- and drug resistance- ...... acute myeloid leukemia (AML).
@en
prefLabel
Oncogene- and drug resistance- ...... acute myeloid leukemia (AML).
@ast
Oncogene- and drug resistance- ...... acute myeloid leukemia (AML).
@en
P2093
P2860
P50
P356
P1433
P1476
Oncogene- and drug resistance- ...... n acute myeloid leukemia (AML)
@en
P2093
Aminetou Mint Mohamed
Catherine Koering
Christiane Pinatel
Claude Preudhomme
Denis Guyotat
Emeline Cros
Eric Wattel
Franck Nicolini
Françoise Solly
Hussein Mortada
P2860
P304
P356
10.18632/ONCOTARGET.3898
P407
P577
2016-01-01T00:00:00Z